TREATMENT PATTERNS OF BIOLOGICS AND APREMILAST AMONG PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS BY PSORIATIC ARTHRITIS STATUS

被引：0
作者：
Feldman, S. R. [1 ]
Zhang, J. [2 ]
Martinez, D. [3 ]
Lopez-Gonzalez, L. [4 ]
Marchlewicz, E. [5 ]
Shrady, G. [4 ]
Lowry, S. [2 ]
Mendelsohn, A. B. [2 ]
Zhao, Y. [2 ]
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[2] Sun Pharmaceut Ind Inc, Princeton, NJ USA
[3] IBM Watson Hlth, Bethesda, MD USA
[4] IBM Watson Hlth, Cambridge, MA USA
[5] IBM Watson Hlth, Ann Arbor, MI USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.123
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI41
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [41] Treatment persistence of biologics among patients with psoriatic arthritis
    Amir Haddad
    Tal Gazitt
    Ilan Feldhamer
    Joy Feld
    Arnon Dov Cohen
    Idit Lavi
    Faten Tatour
    Irena Bergman
    Devy Zisman
    Arthritis Research & Therapy, 23
  • [42] Combination therapy of apremilast and secukinumab in patients with moderate-to-severe, recalcitrant plaque psoriasis
    Sacchelli, L.
    Patrizi, A.
    Loi, C.
    Bardazzi, F.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (07) : E243 - E244
  • [43] BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Kourlaba, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2018, 21 : S424 - S425
  • [44] TREATMENT SATISFACTION AMONG PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS IN BRAZIL
    Lopes, N.
    Suarez, R. M.
    Sabbag, C. Y.
    Kobata, C. M.
    Takemoto, M. S.
    Pertel, P.
    VALUE IN HEALTH, 2017, 20 (09) : A902 - A902
  • [45] Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
    Chiricozzi, Andrea
    De Simone, Clara
    Fossati, Barbara
    Peris, Ketty
    PSORIASIS-TARGETS AND THERAPY, 2019, 9 : 29 - 35
  • [46] Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics
    Sator, P.
    Richter, L.
    Saxinger, W.
    Vasiljevic, M.
    Stingl, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (09) : 1742 - 1749
  • [47] Apremilast in the therapy of moderate to severe chronic plaque psoriasis and special locations
    Fernandez, Alvaro Barranquero
    Perez, Jorge Alonso Suarez
    Acosta, Enrique Herrera
    Fernandez, Maria Victoria Mendiola
    Ceballos, Enrique Herrera
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB46 - AB46
  • [48] Economic and Comorbidity Burden Among Moderate-to-Severe Psoriasis Patients Comorbid with Psoriatic Arthritis
    Feldman, Steven R.
    Zhao, Yang
    Shi, Lizheng
    Lu, Jackie
    Tran, MaryHelen
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S680 - S681
  • [49] Economic and Comorbidity Burden Among Moderate-to-Severe Psoriasis Patients With Comorbid Psoriatic Arthritis
    Feldman, Steven R.
    Zhao, Yang
    Shi, Lizheng
    Mary Helen Tran
    Lu, Jackie
    ARTHRITIS CARE & RESEARCH, 2015, 67 (05) : 708 - 717
  • [50] Nomogram for accurate and quantitative prediction of the risk of psoriatic arthritis in Chinese adult patients with moderate and severe plaque psoriasis
    Zerong Chen
    Yiyi Wang
    Xiaomeng Lan
    Min Yang
    Li Ding
    Gaojie Li
    Peizhen Hong
    Yinling Bai
    Yi Liu
    Wei Li
    European Journal of Dermatology, 2021, 31 : 499 - 507
12345